BioCentury
ARTICLE | Clinical News

CBLB612: Phase II started

February 1, 2016 8:00 AM UTC

Cleveland began a placebo-controlled, Russian Phase II trial to evaluate a single dose of CBLB612 given before or after chemotherapy with doxorubicin and cyclophosphamide in at least 39 breast cancer ...